1. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases
   Tong Wu et al, 2021, OncoTargets and Therapy CrossRef
2. The Novel Diagnostic Techniques and Biomarkers of Canine Mammary Tumors
   Ilona Kaszak et al, 2022, Veterinary Sciences CrossRef
3. MiR-374b-5p Regulates T Cell Differentiation and Is Associated with rEg.P29 Immunity
   Dongjie Li et al, 2020, BioMed Research International CrossRef
4. Application of adoptive cell therapy in hepatocellular carcinoma
   Dengqiang Wu et al, 2023, Immunology CrossRef
5. Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
   Hidetaka Yasuoka et al, 2020, Scientific Reports CrossRef
6. MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
   Laura Gramantieri et al, 2022, Biomolecules CrossRef
7. The Regulatory Effects of MicroRNAs on Tumor Immunity
   Yan Lu et al, 2022, BioMed Research International CrossRef
8. The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
   Fatimat Kipkeeva et al, 2022, International Journal of Molecular Sciences CrossRef
9. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer
   Yicun Jiang et al, 2022, Frontiers in Immunology CrossRef
10. PD-1/PD-L1 axis in organ fibrosis
    Youliang Zhao et al, 2023, Frontiers in Immunology CrossRef
11. mmu-miR-374b-5p modulated inflammatory factors via downregulation of C/EBP β/NF-κB signaling in Kupffer cells during Echinococcus multilocularis infection
    Guiting Pu et al, 2024, Parasites & Vectors CrossRef
12. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy
    Rafaela Nasser Veiga et al, 2022, Systems Biology of MicroRNAs in Cancer CrossRef